Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$53.61M

FY 2025 · Annual

Investing Cash Flow

$46.18M

FY 2025 · Annual

Financing Cash Flow

$10.84M

FY 2025 · Annual

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$29.8M
+ D&A$3.9M
+ Stock-Based Comp$2.9M
+ Deferred Tax$0
- Working Capital-$32.6M
+ Other Non-Cash$2.0M
= Operating Cash Flow-$53.6M
- Capex-$6.4M
= Free Cash Flow-$60.0M

Analysis

FY2025 free cash flow is -$60.0M. FCF conversion is 201.2% of net income. Operating cash flow was -$53.6M, with capex of -$6.4M. The largest bridge item is Working Capital at -$32.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
8-KCurrent reportNov 3, 2026

Does ALMR generate free cash flow?

Alamar Biosciences, Inc. (ALMR) generated -$59.99M of free cash flow in fiscal 2025.

How much operating cash flow does ALMR produce?

Operating cash flow was -$53.61M, before capital expenditures of $6.38M.